Amarin Corp Plc (AMRN)

[VuBru]

Great analytics example (from consulting company report I found): "After German payor G-BA rejected coverage for premium priced Lantus, a form of insulin, Sanofi leveraged real-world research to counter its exclusion from the formulary. It conducted a comparative effectiveness study of Lantus vs. human insulin using data from IMS Health's Disease Analyzer and proved that use of Lantus results in a 17% higher persistence and may delay the need for higher-priced intensive conventional therapy. Using the real-world evidence, G-BA reversed its position. Sanofi has now secured contracts with more than 150 individual payors in Germany covering about 90% of the German population."

Also relevant from this report: "In 2011, AstraZeneca established a 4-year partnership with WellPoint's data/analytic subsidiary HealthCore to conduct real-world studies to determine the most effective and economical treatments for chronic illnesses and other common diseases"

Substitute AMRN for Sanofi....
Not saying it has happened the same with AMRN, but with their CMO Granowitz speaking on uses of big data in healthcare, it would not surprise me in the least. As I have said before, it is possible the company already knows what R-It will show based on big data findings.